aparoscopic versus open abdominal sacral colpopexy for vaginal vault prolapse. A comparison of effectivity, quality of life and costs.

Phase 4

Completed

• Conditions: 10047789; vault prolapse

• Registration Number: NL-OMON30804
• Lead Sponsor: Máxima Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 74

Inclusion Criteria

All hysterectomised patients with a vaginal vault prolapse are elegible for the study.

Exclusion Criteria

Patients with a contraindication for a surgical intervention will be excluded

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>OUTCOME MEASURES: The primary outcome will be quality of life. The urogenital<br /><br>distress inventory (UDI) will be the quality of life measure in this trial. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome will be women*s perceived improvement in the prolapse<br /><br>symptoms and clinicians post-operative grading of prolapse until one year of<br /><br>follow-up, costs and cost-effectiveness.</p><br>